Treatment of hidradenitis suppurativa: is oral isoniazid an option?
Miller
Iben M
IM
Dufour
Deirdre N
DN
Jemec
Gregor B E
GB
D000284:Administration, Oral; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D012720:Severity of Illness Index; D017211:Treatment Failure
D000995:Antitubercular Agents; D007155:Immunologic Factors; D007538:Isoniazid